Alpelisib Structural Formula (Byl719 01)
Piqray Tablet
Product Images NDC 0078-0708
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Piqray (NDC 0078-0708). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1: Progression Free Survival In Solar-1 (per Investigator Assessment Of Patients With A Pik3ca Tumor Mutation) (Byl719 02)
Principal Display Panel Ndc 0078-0708-02 Piqray® (alpelisib) Tablets 300 mg Daily Dose Take Two 150 mg Tablets Once Daily Rx Only Usual Dosage: Take Two 150 mg Tablets Once Daily With Food. Swallow Tablets Whole. Do Not Chew,crush, Or Split Tablets. See Prescribing Information For Complete Dosage Information. 28-day Supply Contains: Two 14-day Blister Packs Each Containing 28 Tablets Novartis (Byl719 03)
L4 Piqray 300 mg daily dose is a medication manufactured by Novartis Pharma Stein AG, distributed by Novartis Pharmaceuticals Corporation, for oral use. The drug, which contains 150mg alpelisib per tablet, is taken twice daily with food. It is important to swallow the tablets whole and not to chew, crush, or split them. It is available in a 28-day supply package containing two blister packs, each pack containing 28 tablets. For complete dosage information, kindly refer to the prescribing information. The drug should be stored between 20°C to 25°C. For more information or in case of queries, visit www.PIQRAY.com or call 1-888-669-6682.*
Principal Display Panel Ndc 0078-0715-02 Piqray® (alpelisib) Tablets 250 mg Daily Dose Take One 200 mg Tablet And One 50 mg Tablet Once Daily Rx Only Usual Dosage: Take One 200 mg Tablet And One 50 mg Tablet Once Daily With Food. Swallow Tablets Whole. Do Not Chew, Crush, Or Split Tablets. See Prescribing Information For Complete Dosage Information. 28-day Supply Contains: Two 14-day Blister Packs Each Containing 28 Tablets: 200 mg 14 Tablets Per Pack 50 mg 14 Tablets Per Pack Novartis (Byl719 04)
PIQRAY is a medicine that comes in tablets and is meant for oral use. This drug is manufactured by Novartis Pharma Stein AG in Switzerland and distributed by Novartis Pharmaceuticals Corporation in the United States. The recommended dosage is one 200mg tablet and one 50mg tablet to be taken once daily with food, and the tablets should not be crushed, chewed, or split. The proper storage temperature of the tablets should be maintained in the range of 20° C to 25° C (68° F to 77° F). PIQRAY is available for prescription only, and more information can be found via the website or phone number provided by Novartis.*
Principal Display Panel Ndc 0078-0701-84 Piqray® (alpelisib) Tablets 200 mg Daily Dose Take One 200 mg Tablet Once Daily Rx Only Usual Dosage: Take One 200 mg Tablet Once Daily With Food. Swallow Tablets Whole. Do Not Chew, Crush, Or Split Tablets. See Prescribing Information For Complete Dosage Information. 28-day Supply Contains: One Blister Pack Containing 28 Tablets Novartis (Byl719 05)
"PIQRAY" tablets (alpelisib 200mg) are taken orally once daily with food. Each pack contains 28 tablets and should be kept in the original container between 20°C to 25°C (68°F to 77°F). Tablets must not be chewed, crushed, or split. PIQRAY is a product of Scvania ENovartis, manufactured by Novartis Pharma Stein AG and distributed by Novartis Pharmaceuticals Corporation. For complete dosage information, please refer to the prescribing information or visit www.PIQRAY.com. Contact 1-888-669-6682 for further inquiries.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
